VBIVQ — VBI Vaccines Share News
0.000.00%
Last trade - 00:00- $0.01m
- $36.16m
- $8.68m
Brief: Vbi Vaccines Announces Dosing Of First Patients In Phase 2B Study Of Vbi-1901 In Recurrent Gbm
Brief: VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results Of Phase 2 Study
Brief: VBI Vaccines Q2 Revenue USD 720 Thousand
VBI Vaccines Inc expected to post a loss of $2.16 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Microsoft, Genius Sports, Thermo Fisher
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Applied Digital, Sweetgreen
U.S. STOCKS ON THE MOVE-First Horizon, Fidelity National, Caribou Biosciences
Brief: Vbi Vaccines Announces Pricing Of $18 Mln Public Offering And $3 Mln Concurrent Registered Direct Offering
VBI Vaccines plunges on stock offerings
Brief: Brii Biosciences Says Entered Into License Agreements With VBI Vaccines
Brief: Vbi Vaccines And Brii Biosciences Expand Hepatitis B Partnership
Brief: Vbi Vaccines Announces Proposed Concurrent Public Offering
Brief: VBI Vaccines Reports First Quarter 2023 Financial Results
VBI Vaccines Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Vbi Vaccines Inc- Company Has Regained Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Vbi Vaccines Appoints Vaughn Himes To Board Of Directors
U.S. STOCKS ON THE MOVE-AMC Entertainment, Trilogy Metals, Nogin
U.S. STOCKS ON THE MOVE-Duckhorn Portfolio, BullFrog AI, VBI Vaccines
VBI Vaccines falls to record low after reverse stock split plans, CFO change